AN ACT TO ENSURE THE PROPER ADMINISTRATION OF STEP THERAPY PROTOCOLS FOR PRESCRIPTION DRUGS.
House committee substitute makes the following changes to the 1st edition.
Amends GS 58-50-315 to add that nothing in the Part is to be construed to impact an insurers' ability to substitute a generic drug for a name brand drug.
Makes clarifying and technical changes throughout.
Changes the effective date of the act from October 1, 2015, to January 1, 2016.
© 2020 School of Government The University of North Carolina at Chapel Hill
This work is copyrighted and subject to "fair use" as permitted by federal copyright law. No portion of this publication may be reproduced or transmitted in any form or by any means without the express written permission of the publisher. Distribution by third parties is prohibited. Prohibited distribution includes, but is not limited to, posting, e-mailing, faxing, archiving in a public database, installing on intranets or servers, and redistributing via a computer network or in printed form. Unauthorized use or reproduction may result in legal action against the unauthorized user.
Beginning January 1, you do not need to log in to view the Daily Bulletin, Bills and Bill Summaries.